2. Gene
  3. F5 - coagulation factor V Gene

F5 - coagulation factor V Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Rattus norvegicus

同用名: Ac2-120

基因 ID: 304929 | 基因类型: protein coding

关于 F5

功能概要

Predicted to enable oxidoreductase activity. Involved in blood coagulation and response to vitamin K. Located in Golgi apparatus; endoplasmic reticulum; and extracellular space. Used to study membranoproliferative glomerulonephritis. Biomarker of hepatitis and portal hypertension. Human ortholog(s) of this gene implicated in several diseases, including artery disease (multiple); end stage renal disease; factor V deficiency; liver disease (multiple); and non-arteritic anterior ischemic optic neuropathy. Orthologous to human F5 (coagulation factor V). [provided by Alliance of Genome Resources, Apr 2022]

F5 基因产物(1)

mRNA Protein Name
NM_001047878.1 NP_001041343.1 coagulation factor V
基因本体论
  • 生物过程
  • 细胞组分
生物过程 GO 注释 逻辑证据 参考文献 来源
involved in response to vitamin K IEP
IEP: 通过表达模式推断
658784 RGD
细胞组分 GO 注释 逻辑证据 参考文献 来源
located in extracellular region IDA
IDA: 通过直接分析推断
15172885 RGD
located in extracellular space IDA
IDA: 通过直接分析推断
3956160 RGD
EXP：通过实验结果推断 IDA：通过直接分析推断 IPI：通过物理相互作用推断 IMP：通过突变表型推断 IGI：通过遗传相互作用推断 IEP：通过表达模式推断
蛋白主名 其他名称

coagulation factor V

coagulation factor V (proaccelerin, labile factor)

相关产品

Approval
生物活性分子 (2)
目录号 产品名 作用方式
纯度 是否罕见病
HY-B1658A Frovatriptan succinate hydrate Agonist 99.60% 否
HY-B1658B Frovatriptan succinate Agonist / 否
Clinical Phase
生物活性分子 (1)
目录号 产品名 作用方式
纯度 Phase
HY-P0039 BIM-26226 Antagonist 99.94% Phase 1
Pre-clinical Phase
生物活性分子 (50)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-112698 CA-5f 99.14% 否
HY-108277 Ginsenoside F5 Inducer 99.76% 否
HY-W093272 Thalidomide-5,6-F Inducer 99.84% 否
HY-124421 5F-203 Inducer 99.04% 否
HY-W010811 Fmoc-Phe(F5)-OH 99.08% 否
HY-P5367 5-FAM-PMDM6 97.02% 否
HY-118847 Antifungal agent 86 Inhibitor / 否
HY-147698 ZLHQ-5f / 否
HY-B1658BS Frovatriptan-d3 succinate Agonist / 否
HY-D1410 DMTr-4'-F-5-Me-U-CED phosphoramidite / 否
HY-D1758 Fura-5F AM / 否
HY-D1779 Fura-5F pentapotassium / 否
HY-N8311 Goshonoside F5 Inhibitor / 否
HY-P2579 Dafphedyn Agonist / 否
HY-P4020 2F5 epitope / 否
HY-P4025 ELDKWA / 否
HY-R01575 hsa-miR-518f-5p mimic / 否
HY-R01575A hsa-miR-518f-5p agomir / 否
HY-R01604 hsa-miR-520f-5p mimic / 否
HY-R01604A hsa-miR-520f-5p agomir / 否
HY-R01684 hsa-miR-548f-5p mimic / 否
HY-R01684A hsa-miR-548f-5p agomir / 否
HY-R03052 mmu-miR-344f-5p mimic / 否
HY-R03052A mmu-miR-344f-5p agomir / 否
HY-R03177 mmu-miR-466f-5p mimic / 否
HY-R03177A mmu-miR-466f-5p agomir / 否
HY-R03468 mmu-miR-669f-5p mimic / 否
HY-R03468A mmu-miR-669f-5p agomir / 否
HY-RI01575 hsa-miR-518f-5p inhibitor / 否
HY-RI01575A hsa-miR-518f-5p antagomir / 否
HY-RI01604 hsa-miR-520f-5p inhibitor / 否
HY-RI01604A hsa-miR-520f-5p antagomir / 否
HY-RI01684 hsa-miR-548f-5p inhibitor / 否
HY-RI01684A hsa-miR-548f-5p antagomir / 否
HY-RI03052 mmu-miR-344f-5p inhibitor / 否
HY-RI03052A mmu-miR-344f-5p antagomir / 否
HY-RI03177 mmu-miR-466f-5p inhibitor / 否
HY-RI03177A mmu-miR-466f-5p antagomir / 否
HY-RI03468 mmu-miR-669f-5p inhibitor / 否
HY-RI03468A mmu-miR-669f-5p antagomir / 否
HY-RS04114 E2F5 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS04644 F5 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS09816 OR4F5 Human Pre-designed siRNA Set A Pre-designed Set / 否
HY-R04617 mmu-let-7f-5p mimic / 否
HY-RS16905 F5 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS20723 E2f5 Mouse Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS23347 F5 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-RS27235 E2f5 Rat Pre-designed siRNA Set A Pre-designed Set / 否
HY-W453715 Thalidomide-4-F,5-Br 99.37% 否
HY-W586320 Thalidomide-5-Br,6-F / 否
抗体抑制剂 (2)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P990255 Anti-Mouse CXCL9/MIG Antibody (MIG-2F5.5) 95.00% 否
HY-P990221 Anti-Mouse IL-17F Antibody (MM17F8F5.1A9) Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens F5 NCBI NCBI:2153
Canis familiaris F5 NCBI NCBI:100685858
Macaca fascicularis F5 NCBI NCBI:102141482
Mus musculus F5 NCBI NCBI:14067
Leporidae F5 NCBI
Macaca mulatta F5 NCBI NCBI:704695
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z